Showing 91 - 100 of 7,703
New data on Medicaid prescription drug use and reimbursement in 1999, prepared by Mathematica for the Centers for Medicare & Medicaid Services, provide a tool states can use to identify potential problems in their Medicaid prescription drug programs and explore solutions. The data are organized...
Persistent link: https://www.econbiz.de/10010925141
Persistent link: https://www.econbiz.de/10010925244
Persistent link: https://www.econbiz.de/10010925267
This issue brief highlights a number of prescription drug issues that remain important for states after the shift of prescription drug coverage for Medicaid-Medicare dual eligibles to Medicare in 2006, including the use of antipsychotic drugs in nursing facilities and other settings. It focuses...
Persistent link: https://www.econbiz.de/10010925313
Persistent link: https://www.econbiz.de/10010923478
The new Medicare Part D benefit, which began on January 1, 2006, expanded Medicare to include prescription drugs, and it required beneficiaries to change how they interact with the program. Past experience with low enrollment in a variety of programs designed to aid low-income Medicare...
Persistent link: https://www.econbiz.de/10010923480
Persistent link: https://www.econbiz.de/10010923509
This technical assistance brief, prepared for the Integrated Care Resource Center, provides basic information for states participating in the Centers for Medicare & Medicaid Services’ capitated Financial Alignment Demonstration covering Medicare-Medicaid enrollees. Although not a...
Persistent link: https://www.econbiz.de/10011144831
This brief presents noteworthy trends and patterns in the use and costs of prescription drugs for Medicaid beneficiaries from 1999 to 2009. It builds on previous annual tables and chartbooks, and describes trends in drug usage and costs. The brief emphasizes trends for beneficiaries with...
Persistent link: https://www.econbiz.de/10010643063
Persistent link: https://www.econbiz.de/10010608729